Healthcare Research Agency Faces Crisis Amidst Budget Cuts
The Agency for Healthcare Research and Quality (AHRQ) is "on the brink" due to significant staff reductions and grant cancellations under the Trump administration, according to experts. Its future is uncertain.
The federal Agency for Healthcare Research and Quality (AHRQ), tasked with studying improvements to the U.S. healthcare system, is reportedly "on the brink." Experts warn that drastic measures by the Trump administration, including a 75 percent staff reduction and widespread grant cancellations, have jeopardized the agency's operations.
Health policy experts Aaron Carroll and David Atkins stated in a published opinion piece that the agency's survival under a potential second Trump administration is "an open question." AHRQ, established to enhance patient safety, healthcare quality, and the adoption of new technologies, has faced significant funding challenges.
Historically, bipartisan support existed for addressing healthcare disparities as quality issues. However, recent political shifts have politicized these disparities. The agency's substantial appropriated funds remain unspent, further impacting its ability to conduct vital research.
The extensive cuts and funding freeze raise concerns about the future of critical healthcare research in the United States and the agency's capacity to fulfill its mandate.